| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Pesticides & Agrochemicals
|
Compare with Industry peers |
| Website | http://www.punjabchemicals.com | |
| Market Cap | 1,349.51 Cr. | |
| Enterprise Value(EV) | 1,437.93 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 44.35 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 24.82 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 53.00 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 267.61 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 4.11 | Calculated using Price: 1,100.55 |
| Dividend Yield | 0.27 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.23 Cr. | 12,262,185 Shares |
| FaceValue | 10 | |
| About Punjab Chemicals & Crop Protection Ltd. | ||
| Punjab Chemicals & Pharmaceuticals (PCPL), the company is engaged in manufacturing of agrochemicals, pharmaceutical intermediates, APIs, phosphorous derivatives and specialty chemicals.The company also undertakes contract manufacturing of chemicals for various companies.The company is engaged into manufactures a range of crop protections production in various forms.The company is into manufacturing of pharmaceutical drugs and APIs.It is engaged in manufacturing of phosphoric acid, phosphorus pentoxide, phosphorous trichloride, phosphorous oxychloride, phosphorous acid and various phosphates.PCCPL manufactures a portfolio of products such as inorganic chemicals, organic chemicals, pharmaceutical and dyes intermediates, food and feed additives, specialty chemicals, laboratory chemicals and natural products and herbal extracts | ||
| 1 Day |
|
+1.84% |
| 1 Week |
|
+6.13% |
| 1 Month |
|
+12.22% |
| 3 Month |
|
-7.53% |
| 6 Month |
|
-2.04% |
| 1 Year |
|
+35.19% |
| 2 Year |
|
-23.36% |
| 5 Year |
|
+57.99% |
| 10 Year |
|
+1449.30% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 0 | 0 | -60.35 | 25.92 | 20.36 | 11.4 | 40.52 | 45.1 | 24.14 | |
| Return on Capital Employed (%) | 15.92 | 26.16 | 5.62 | 20.93 | 24.65 | 21.21 | 38.41 | 44.96 | 30.83 | |
| Return on Assets (%) | 2.83 | 2.83 | -4.5 | 4.4 | 4.57 | 2.72 | 11.05 | 15.39 | 9.38 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | -35 | 61 | 58 | 74 | 91 | 98 | 145 | 226 | 281 | 317 | |
| Non Curr. Liab. | 188 | 165 | 74 | 63 | 44 | 82 | 108 | 97 | 105 | 88 | |
| Curr. Liab. | 328 | 231 | 296 | 215 | 247 | 229 | 228 | 283 | 313 | 253 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 482 | 457 | 428 | 353 | 382 | 409 | 480 | 605 | 699 | 658 | |
| Non Curr. Assets | 277 | 275 | 248 | 193 | 207 | 211 | 233 | 249 | 268 | 258 | |
| Curr. Assets | 206 | 183 | 180 | 160 | 175 | 197 | 247 | 355 | 430 | 400 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 482 | 457 | 428 | 353 | 382 | 409 | 480 | 605 | 699 | 658 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 565 | 538 | 525 | 493 | 643 | 550 | 678 | 933 | 1,006 | 933 | |
| Other Income | 23 | 16 | 13 | 11 | 7 | 13 | 2 | 1 | 3 | 4 | |
| Total Income | 588 | 554 | 537 | 504 | 650 | 563 | 680 | 934 | 1,010 | 937 | |
| Total Expenditure | -518 | -497 | -510 | -452 | -577 | -507 | -583 | -794 | -884 | -812 | |
| PBIDT | 71 | 57 | 28 | 53 | 73 | 56 | 97 | 141 | 126 | 124 | |
| Interest | -35 | -50 | -31 | -18 | -17 | -18 | -13 | -12 | -18 | -23 | |
| Depreciation | -19 | -17 | -16 | -14 | -19 | -15 | -15 | -17 | -19 | -21 | |
| Taxation | -1 | -1 | -1 | -7 | -12 | -11 | -20 | -28 | -28 | -26 | |
| Exceptional Items | -2 | 24 | 3 | -8 | |||||||
| PAT | 14 | 13 | -20 | 17 | 17 | 11 | 49 | 83 | 61 | 54 | |
| Minority Interest | |||||||||||
| Share Associate | 0 | ||||||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | 14 | 13 | -20 | 17 | 17 | 11 | 49 | 83 | 61 | 54 | |
| Adjusted EPS | 12 | 11 | -16 | 14 | 14 | 9 | 40 | 68 | 50 | 44 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 38 | 57 | 105 | 62 | 61 | 68 | 34 | 43 | 34 | 58 | |
| Cash Fr. Inv. | -2 | 10 | 11 | -8 | -15 | -21 | -14 | -8 | -27 | -36 | |
| Cash Fr. Finan. | -20 | -72 | -141 | -61 | -43 | -4 | -19 | -24 | -11 | -20 | |
| Net Change | 16 | -4 | -26 | -7 | 4 | 44 | 2 | 11 | -4 | 2 | |
| Cash & Cash Eqvt | 28 | 14 | 5 | -44 | -44 | 1 | 2 | 12 | 8 | 9 |
|
Fri, 12 Apr 2024
Board Meeting Intimation for Consideration And Approval Of Financial Results For The Quarter/Year Ended March 31 2024 PUNJAB CHEMICALS AND CROP PROTECTION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2024 inter alia to consider and approve 1. Audited (Standalone and Consolidated) Financial Results of the Company for the quarter / year ended March 31 2024; 2. Approve and take on record the Audited (Standalone and Consolidated) Financial Statements of the Company for the year ended March 31 2024 along with the Audit Report; and 3.Recommend a Final Dividend if any on the Equity Shares of the Company for the year ended March 31 2024. |
|
Fri, 12 Apr 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of Loss of share certificate(s) |
|
Wed, 10 Apr 2024
Certificate Under Regulation 40(9) And 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended March 31 2024 Compliance certificate u/r 40(9) and 40(10) of the SEBI (LODR) Regulations 2015 for the year ended March 31 2024. |
| Fri, 19 Apr 2024 |
High Increase in 1 Month
|
High Increase in 1 Year
|
CCI Overbought Zone
|
MFI Above 80
|
Close Crossing 200 SMA From Below
|
